STOCK TITAN
  1. Home
  2. Sec-filings
  3. HCWB
  4. [EFFECT] HCW Biologics Inc. SEC Filing

[EFFECT] HCW Biologics Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 29, 2026 3:00 P.M.
Form: S-1
CIK: 0001828673
Company Name: HCW Biologics Inc.
File Number: 333-292652

Source: View Original Filing on SEC EDGAR

Hcw Biologics Inc.

NASDAQ:HCWB

View HCWB Stock Overview →

HCWB Rankings

#7024 Ranked by Market Cap
N/A Ranked by Dividends

HCWB Latest News

Mar 17, 2026
HCW Biologics Closes Exclusive Worldwide License for HCW11-006 – A High Potential Fusion Immunotherapeutic
Mar 16, 2026
HCW Biologics Announces Positive Research Results for CAR-T Cell Therapy Manufactured Utilizing Its Commercial-Ready Proprietary Compound, HCW9206, Published in Science Advances
Mar 2, 2026
HCW Biologics Regains Compliance with All Continued Listing Rules for Nasdaq Per Nasdaq Determination Letter
Feb 17, 2026
HCW Biologics Announces Pricing of $1.5 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
Feb 13, 2026
HCW Biologics and WY Biotech Announce Closing of First Round of Financing For Newly Formed Joint Venture Trimmune

HCWB Latest SEC Filings

Mar 17, 2026
[8-K] HCW Biologics Inc. Reports Material Event
Mar 13, 2026
[DEF 14A] HCW Biologics Inc. Definitive Proxy Statement
Mar 3, 2026
[PRE 14A] HCW Biologics Inc. Preliminary Proxy Statement
Mar 2, 2026
[8-K] HCW Biologics Inc. Reports Material Event
Feb 19, 2026
[8-K] HCW Biologics Inc. Reports Material Event

HCWB Stock Data

1.31M
2.93M
Biotechnology
Pharmaceutical Preparations
Link
United States
MIRAMAR